SLC13A5 and hepatocellular carcinoma: In mice, knockout of a DASS family member (NaCT, SLC13A5 in humans) leads to protection against adiposity and insulin resistance (6), and knockout of the equivalent transporter in human hepatocarcinoma cells substantially reduces hepatoma cell proliferation and colony formation (7).